These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 21656523

  • 1. Treatment strategy for early hepatocellular carcinomas: comparison of radiofrequency ablation with or without transcatheter arterial chemoembolization and surgical resection.
    Tashiro H, Aikata H, Waki K, Amano H, Oshita A, Kobayashi T, Tanimoto Y, Kuroda S, Tazawa H, Chayama K, Asahara T, Ohdan H.
    J Surg Oncol; 2011 Jul 01; 104(1):3-9. PubMed ID: 21656523
    [Abstract] [Full Text] [Related]

  • 2. Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone.
    Kim JH, Won HJ, Shin YM, Kim SH, Yoon HK, Sung KB, Kim PN.
    Ann Surg Oncol; 2011 Jun 01; 18(6):1624-9. PubMed ID: 21445671
    [Abstract] [Full Text] [Related]

  • 3. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection.
    Kagawa T, Koizumi J, Kojima S, Nagata N, Numata M, Watanabe N, Watanabe T, Mine T, Tokai RFA Study Group.
    Cancer; 2010 Aug 01; 116(15):3638-44. PubMed ID: 20564097
    [Abstract] [Full Text] [Related]

  • 4. Radiofrequency ablation combined with chemoembolization: treatment of recurrent hepatocellular carcinomas after hepatectomy.
    Takaki H, Yamakado K, Sakurai H, Nakatsuka A, Shiraki K, Isaji S, Takeda K.
    AJR Am J Roentgenol; 2011 Aug 01; 197(2):488-94. PubMed ID: 21785099
    [Abstract] [Full Text] [Related]

  • 5. Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma.
    Helmberger T, Dogan S, Straub G, Schrader A, Jüngst C, Reiser M, Waggershauser T, Jakobs T, Hoffmann RT, Löhe F, Graeb C, Rau HG, Schauer R, Jauch KW, Caselmann WH, Göke B, Jüngst D.
    Digestion; 2007 Aug 01; 75(2-3):104-12. PubMed ID: 17598962
    [Abstract] [Full Text] [Related]

  • 6. Transcatheter arterial chemoembolization combined with radiofrequency ablation for the treatment of hepatocellular carcinoma.
    Peng ZW, Chen MS.
    Oncology; 2013 Aug 01; 84 Suppl 1():40-3. PubMed ID: 23428857
    [Abstract] [Full Text] [Related]

  • 7. Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: comparative effectiveness of treatment modalities.
    Ho CM, Lee PH, Shau WY, Ho MC, Wu YM, Hu RH.
    Surgery; 2012 May 01; 151(5):700-9. PubMed ID: 22284764
    [Abstract] [Full Text] [Related]

  • 8. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma].
    Xu ZM, Wang JH, Zhen ZJ, Chen HW, Cui WZ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov 01; 26(11):1626-8. PubMed ID: 17121718
    [Abstract] [Full Text] [Related]

  • 9. [Radiofrequency ablation combined with transcatheter arterial chemoembolization for the local recurrent tumor after resection of the adrenal metastasis from hepatocellular carcinoma--a case report].
    Yasumoto T, Hayashi S, Shimizu J, Dono K, Nakata S, Sato M, Kitada M, Shimano T.
    Gan To Kagaku Ryoho; 2009 Nov 01; 36(12):2371-3. PubMed ID: 20037426
    [Abstract] [Full Text] [Related]

  • 10. Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization.
    Morimoto M, Numata K, Kondou M, Nozaki A, Morita S, Tanaka K.
    Cancer; 2010 Dec 01; 116(23):5452-60. PubMed ID: 20672352
    [Abstract] [Full Text] [Related]

  • 11. Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation.
    Heckman JT, Devera MB, Marsh JW, Fontes P, Amesur NB, Holloway SE, Nalesnik M, Geller DA, Steel JL, Gamblin TC.
    Ann Surg Oncol; 2008 Nov 01; 15(11):3169-77. PubMed ID: 18696158
    [Abstract] [Full Text] [Related]

  • 12. Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: Short-term recurrences and survival.
    Yamakado K, Nakatsuka A, Akeboshi M, Shiraki K, Nakano T, Takeda K.
    Oncol Rep; 2004 Jan 01; 11(1):105-9. PubMed ID: 14654911
    [Abstract] [Full Text] [Related]

  • 13. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
    Yamagiwa K, Shiraki K, Yamakado K, Mizuno S, Hori T, Yagi S, Hamada T, Iida T, Nakamura I, Fujii K, Usui M, Isaji S, Ito K, Tagawa S, Takeda K, Yokoi H, Noguchi T.
    J Gastroenterol Hepatol; 2008 Mar 01; 23(3):482-90. PubMed ID: 18086115
    [Abstract] [Full Text] [Related]

  • 14. [Effectiveness of radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Gao HJ, Liang HH, Chen MS, Peng ZW, Zhang YJ, Li P, Pang XH, Zhang YQ, Li JQ.
    Zhonghua Yi Xue Za Zhi; 2008 Sep 23; 88(36):2529-32. PubMed ID: 19080642
    [Abstract] [Full Text] [Related]

  • 15. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
    Waki K, Aikata H, Katamura Y, Kawaoka T, Takaki S, Hiramatsu A, Takahashi S, Toyota N, Ito K, Chayama K.
    J Gastroenterol Hepatol; 2010 Mar 23; 25(3):597-604. PubMed ID: 20074153
    [Abstract] [Full Text] [Related]

  • 16. [Comparision of different interventional therapies for primary liver cancer].
    Liu YM, Qin H, Wang CB, Fang XH, Ma QY.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar 23; 29(3):232-5. PubMed ID: 17649645
    [Abstract] [Full Text] [Related]

  • 17. Multimodality treatment with conventional transcatheter arterial chemoembolization and radiofrequency ablation for unresectable hepatocellular carcinoma.
    Ashoori N, Paprottka P, Trumm C, Bamberg F, Kolligs FT, Rentsch M, Reiser MF, Jakobs TF.
    Digestion; 2012 Mar 23; 85(1):18-26. PubMed ID: 22156507
    [Abstract] [Full Text] [Related]

  • 18. A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Peng ZW, Chen MS, Liang HH, Gao HJ, Zhang YJ, Li JQ, Zhang YQ, Lau WY.
    Eur J Surg Oncol; 2010 Mar 23; 36(3):257-63. PubMed ID: 19643561
    [Abstract] [Full Text] [Related]

  • 19. Radiofrequency ablation and chemoembolization for hepatocellular carcinoma.
    Georgiades CS, Hong K, Geschwind JF.
    Cancer J; 2008 Mar 23; 14(2):117-22. PubMed ID: 18391617
    [Abstract] [Full Text] [Related]

  • 20. [Clinical outcomes of radiofrequency ablation combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: a single-center experience].
    Lin JJ, Wu W, Jiang XF, Jin XJ, Lu LJ, Bao LW.
    Zhonghua Zhong Liu Za Zhi; 2013 Feb 23; 35(2):144-7. PubMed ID: 23714672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.